Back
Catalyst Pharmaceuticals Stock Price Chart
![](/images/offers/ims/large/offer5.jpg)
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.
Buy
64
CPRX
Catalyst Pharmaceuticals
Last Price:
17.59
Seasonality Move:
14.5%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer4.jpg)
$1,300 into $45,000 in just 4 MONTHS?!
See here to see the full details.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.
Catalyst Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.13 | Buy |
20-day SMA: | 16.29 | Buy |
50-day SMA: | 16.02 | Buy |
200-day SMA: | 14.98 | Buy |
8-day EMA: | 17.09 | Buy |
20-day EMA: | 16.54 | Buy |
50-day EMA: | 16.06 | Buy |
200-day EMA: | 15.2 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.48 | Buy |
Relative Strength Index (14 RSI): | 67.12 | Buy |
Chaikin Money Flow: | -925890 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.25 - 16.93) | Buy |
Bollinger Bands (100): | (15.17 - 16.51) | Buy |
Catalyst Pharmaceuticals Technical Analysis
Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 17.37 while CPRX 8-day simple moving average is 17.13, which is a Buy signal.
- The stock price of CPRX is 17.37 while Catalyst Pharmaceuticals 20-day SMA is 16.29, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day simple moving average is 16.02 while CPRX share price is 17.37, making it a Buy technically.
- CPRX stock price is 17.37 and Catalyst Pharmaceuticals 200-day simple moving average is 14.98, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
64
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a Buy
The current Catalyst Pharmaceuticals [CPRX] share price is $17.37. The Score for CPRX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.05B
Price in USD:
17.37
Share Volume:
1.1M
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
17.99
52-Week Low:
11.55
Buy
64
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?
The Catalyst Pharmaceuticals stock price is 17.37 USD today. -
Will CPRX stock go up or go down?
Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Catalyst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 17.37 while CPRX 8-day exponential moving average is 17.09, which is a Buy signal.
- The stock price of CPRX is 17.37 while Catalyst Pharmaceuticals 20-day EMA is 16.54, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day exponential moving average is 16.06 while CPRX share price is 17.37, making it a Buy technically.
- CPRX stock price is 17.37 and Catalyst Pharmaceuticals 200-day simple moving average is 15.20, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.13 per share, and an increase next year of $0.17 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
- CPRX Moving Average Covergence Divergence (MACD) indicator is 0.48, suggesting Catalyst Pharmaceuticals is a Buy
- Catalyst Pharmaceuticals Relative Strength Index (RSI) is 67.12, which suggest Catalyst Pharmaceuticals is overbought
- The Bollinger Bands (25) for Catalyst Pharmaceuticals is (15.25 - 16.93), which suggest Catalyst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Catalyst Pharmaceuticals is (15.17 - 16.51), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.